
News|Slideshows|December 23, 2025
Top Five Prostate Cancer Imaging Content in 2025
Author(s)Diagnostic Imaging Staff
Catch up on the most well-viewed prostate cancer imaging content from 2025.
Advertisement
We take a look back at the most well-viewed prostate cancer (PCa) imaging content from 2025 with topics ranging from the prognostic value of baseline PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) and the potential of abbreviated MRI for imaging of clinically significant prostate cancer (csPCa) to a meta-analysis examining the use of PSMA PET for detecting PCa recurrence and metastasis. Review the slideshow below to see highlighted PCa imaging content from the past year.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Emerging PET Radiotracer May Enhance Detection of Small Metastases in Patients with Advanced Melanoma
2
FDA Clears CT-Based AI Software for Detection and Triage of Vascular Occlusion in Lower Extremities
3
Molecular Imaging in Focus: A Closer Look at the Merits of PSMA PET in Staging Patients with Osseous Oligometastatic PCa
4
What a Meta-Analysis Reveals About FAPI PET/CT for Detection of Peritoneal Metastases
5















